The clinical process of restoring the circulating levels and biological efficacy of hormones that signal fullness and inhibit food intake to their optimal, healthy physiological ranges. Satiety hormones, such as leptin, PYY, and CCK, play a crucial role in regulating appetite, energy balance, and body weight. Normalization is a primary goal in managing weight dysregulation and improving metabolic health.
Origin
This term is rooted in the discovery of key appetite-regulating hormones within the gut-brain axis, particularly after the identification of leptin in the mid-1990s. The concept of “normalization” is a therapeutic objective, aiming to correct the resistance or deficiency states often observed in metabolic disorders. It represents a targeted approach to leveraging the body’s intrinsic appetite control mechanisms.
Mechanism
Normalization primarily involves optimizing the function of leptin, which is secreted by adipose tissue and signals long-term energy sufficiency to the hypothalamus. It also focuses on enhancing the post-prandial release of gut-derived hormones like Peptide YY (PYY) and Cholecystokinin (CCK), which signal acute satiety. Strategies to improve insulin sensitivity and reduce chronic inflammation are essential, as these factors directly contribute to the development of leptin resistance, thereby disrupting the crucial satiety signaling pathway.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.